In a time where FDA sponsored initiatives such as Lean 6 Sigma, QbD and PAT are set to dominate the future of Pharmaceutical Manufacture, the industry is becoming ever more aware that controlling particle size for API and excipients via physical milling is not ideal, having a dramatically negative effect on a range of newly understood key physicochemical parameters and ultimately drug product performance.
|
|
More product innovations from Prosonix - Making Better Medicines
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
